Effect of Tanshione II A on TGF-β_1/smad Signaling Pathway in Human Renal Epithelial Cells
Zhao Fe
Abstract
Zhao Fe
Abstract
Objective: To explore the mechanism of the effect of Tanshione ⅡA on renal interstitial fibrosis. Methods:Human renal tubular epithelial cells( HK-2) cultivated in vitro were randomly divided into blank control group,TGF-β1group( TGF-β1,10 ng/ml),low dose Tanshione ⅡA group( Tanshione ⅡA 1 μg/ml + TGF-β110 ng /ml),medium dose Tanshione ⅡA group( Tanshione ⅡA 5 μg /ml + TGF-β110ng /ml) and high dose Tanshione ⅡA group( Tanshione ⅡA10 μg /ml + TGF-β110 ng /ml). Each group was intervened by corresponding measures and the cell supernatant was sucked up. Content of collagen Ⅲ was detected by ELISA and protein expressions of smad2 and smad3 were detected after cell lysis by Western blotting. Results: Compared with the blank control group,the expression of collagen Ⅲ in the TGF-β1group was increased significantly. After added with the Tanshione ⅡA,the expression of collagen Ⅲ in three Tanshione ⅡA groups were decreased,with dose-effect relationship; expressions of smad2 and smad3 protein in the TGF-β1group was significantly increased. Expressions of smad2 and smad3 protein in the Tanshione ⅡA groups were lower than those of the TGF-β1group,but without dose-effect relationship. Conclusion: Tanshione ⅡA can inhibit the secretion of collagen Ⅲ induced by TGF-β1and inhibit the expressions of smad2 and smad3 protein mediated by TGF-β1. It suggests that Tanshione ⅡA maybe act on renal interstitial fibrosis by inhibiting the expressions of smad2 and smad3 protein on TGF-β1/smad signaling pathway.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To explore the mechanism of the effect of Tanshione ⅡA on renal interstitial fibrosis. Methods:Human renal tubular epithelial cells( HK-2) cultivated in vitro were randomly divided into blank control group,TGF-β1group( TGF-β1,10 ng/ml),low dose Tanshione ⅡA group( Tanshione ⅡA 1 μg/ml + TGF-β110 ng /ml),medium dose Tanshione ⅡA group( Tanshione ⅡA 5 μg /ml + TGF-β110ng /ml) and high dose Tanshione ⅡA group( Tanshione ⅡA10 μg /ml + TGF-β110 ng /ml). Each group was intervened by corresponding measures and the cell supernatant was sucked up. Content of collagen Ⅲ was detected by ELISA and protein expressions of smad2 and smad3 were detected after cell lysis by Western blotting. Results: Compared with the blank control group,the expression of collagen Ⅲ in the TGF-β1group was increased significantly. After added with the Tanshione ⅡA,the expression of collagen Ⅲ in three Tanshione ⅡA groups were decreased,with dose-effect relationship; expressions of smad2 and smad3 protein in the TGF-β1group was significantly increased. Expressions of smad2 and smad3 protein in the Tanshione ⅡA groups were lower than those of the TGF-β1group,but without dose-effect relationship. Conclusion: Tanshione ⅡA can inhibit the secretion of collagen Ⅲ induced by TGF-β1and inhibit the expressions of smad2 and smad3 protein mediated by TGF-β1. It suggests that Tanshione ⅡA maybe act on renal interstitial fibrosis by inhibiting the expressions of smad2 and smad3 protein on TGF-β1/smad signaling pathway.
Key concepts: SMAD, Transforming growth factor, Internal medicine, Endocrinology, Secretion, Blot, Fibrosis, Chemistry